Effects of electro-scalp acupuncture on inflammatory response and microglial polarization in the ischemic cortex of rats with ischemic stroke.
10.13703/j.0255-2930.20221124-k0001
- Author:
Xiao-Yun PENG
1
;
Bo YUAN
2
;
Tian TIAN
3
;
Wen-Jun LUO
3
;
Ling-Gui ZHU
3
;
Yan-Ju ZHANG
3
;
Ying LI
3
;
Xiao-Zheng DU
4
;
Jin-Hai WANG
3
Author Information
1. Department of Rehabilitation Medicine, Second Hospital of Lanzhou University, Lanzhou 730030, Gansu Province, China.
2. Clinical Centre of Acupuncture-Moxibustion, Affiliated Hospital of Gansu University of TCM.
3. Department of TCM, Second Hospital of Lanzhou University, Lanzhou 730030, Gansu Province, China.
4. College of Acupuncture-Moxibustion and Tuina, Gansu University of TCM.
- Publication Type:Journal Article
- Keywords:
electro-scalp acupuncture;
inflammatory response;
ischemic stroke;
microglia;
neurological function
- MeSH:
Male;
Animals;
Rats;
Rats, Sprague-Dawley;
Ischemic Stroke;
Interleukin-10;
Interleukin-6/genetics*;
Microglia;
Scalp;
Acupuncture Therapy;
Vitamins;
Infarction, Middle Cerebral Artery
- From:
Chinese Acupuncture & Moxibustion
2023;43(9):1050-1055
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effects of electro-scalp acupuncture （ESA） on the expression of microglial markers CD206 and CD32, as well as interleukin (IL)-6, IL-1β, and IL-10 in the ischemic cortex of rats with ischemic stroke, and to explore the mechanisms of ESA on alleviating inflammatory damage of ischemic stroke.
METHODS:Sixty 7-week-old male SD rats were randomly selected, with 15 rats assigned to a sham surgery group. The remaining rats were treated with suture method to establish rat model of middle cerebral artery occlusion (MCAO). The rats with successful model were randomly divided into a model group, a VitD3 group, and an ESA group, with 15 rats in each group. In the ESA group, ESA was performed bilaterally at the "top-temporal anterior oblique line" with disperse-dense wave, a frequency of 2 Hz/100 Hz, and an intensity of 1 mA. Each session lasted for 30 min, once daily, for a total of 7 days. The VitD3 group were treated with intragastric administration of 1,25-dihydroxyvitamin D3 (1,25-VitD3) solution (3 ng/100 g), once daily for 7 days. The neurological deficit scores and neurobehavioral scores were assessed before and after the intervention. After the intervention, the brain infarct volume was evaluated using 2,3,5-triphenyltetrazolium chloride (TTC) staining. Immunofluorescence double staining was performed to detect the protein expression of CD32 and CD206 in the ischemic cortex. Western blot analysis was conducted to measure the protein expression of IL-6, IL-1β, and IL-10 in the ischemic cortex.
RESULTS:Compared with the sham surgery group, the model group showed increased neurological deficit scores and neurobehavioral scores (P<0.01), increased brain infarct volume (P<0.01), increased protein expression of CD32, IL-6, and IL-1β in the ischemic cortex (P<0.01), and decreased protein expression of CD206 and IL-10 in the ischemic cortex (P<0.01). Compared with the model group, both the ESA group and the VitD3 group showed decreased neurological deficit scores and neurobehavioral scores (P<0.01), reduced brain infarct volume (P<0.01), decreased protein expression of CD32, IL-6, and IL-1β in the ischemic cortex (P<0.01), and increased protein expression of CD206 and IL-10 in the ischemic cortex (P<0.01). Compared with the VitD3 group, the ESA group had lower neurological deficit score (P<0.05), larger brain infarct volume (P< 0.05), and lower protein expression of CD32, CD206, IL-1β, and IL-10 in the ischemic cortex (P<0.01, P<0.05).
CONCLUSION:ESA could improve neurological function in MCAO rats, and its mechanism may be related to promoting microglial M1-to-M2 polarization and alleviating inflammatory damage.
